Considering that increasing SIRT1 activity decreased the MND volume (i.e., increased the number of nuclei), it will be of interest in future studies to investigate SIRT1 as a therapeutic target, for diseases where nuclear alteration is part of the pathophysiology, such as in muscular dystrophies. This evidence concerns the gene SIRT1 and muscular dystrophy.